Garlic: Difference between revisions
From Glioblastoma Treatments
Jump to navigationJump to search
No edit summary |
(Updated category= to treatment_category= in TreatmentInfo template) |
||
| Line 9: | Line 9: | ||
|usefulness_rating=3 | |usefulness_rating=3 | ||
|notes=Garlic, recognized for centuries for its medicinal properties, has shown promise in preclinical studies for its potential anti-cancer effects. These include inducing apoptosis in glioblastoma cell lines and acting as a potent HDAC inhibitor. While these mechanisms suggest garlic could play a role in cancer prevention and possibly treatment, comprehensive clinical trials are needed to substantiate its efficacy and determine its therapeutic utility in oncology. | |notes=Garlic, recognized for centuries for its medicinal properties, has shown promise in preclinical studies for its potential anti-cancer effects. These include inducing apoptosis in glioblastoma cell lines and acting as a potent HDAC inhibitor. While these mechanisms suggest garlic could play a role in cancer prevention and possibly treatment, comprehensive clinical trials are needed to substantiate its efficacy and determine its therapeutic utility in oncology. | ||
| | |treatment_category=Nutraceuticals | ||
|links= | |links= | ||
|toxicity_level=1 | |toxicity_level=1 | ||
|toxicity_explanation=Garlic is used as a dietary supplement and is generally well-tolerated by most people. The most common side effects reported include gastrointestinal discomfort and a strong odor. There is currently not enough research to suggest that garlic as a treatment for glioblastoma has severe toxic side effects. So, it has a low toxicity level of 1. | |toxicity_explanation=Garlic is used as a dietary supplement and is generally well-tolerated by most people. The most common side effects reported include gastrointestinal discomfort and a strong odor. There is currently not enough research to suggest that garlic as a treatment for glioblastoma has severe toxic side effects. So, it has a low toxicity level of 1. | ||
}} | }} | ||
Latest revision as of 10:31, 12 November 2024
| Property | Information |
|---|---|
| Drug Name | Garlic (Allium sativum) |
| FDA Approval | No (Utilized as a dietary supplement; not FDA-approved for cancer treatment) |
| Used for | Investigational use in oncology, focusing on its cytotoxic effects against cancer cells and HDAC inhibition |
| Clinical Trial Phase | Mostly preclinical, involving cell culture studies and some early-stage human research |
| Clinical Trial Explanation | Not specified |
| Common Side Effects | Generally well-tolerated; known side effects include gastrointestinal discomfort and a strong odor. Rare cases of allergic reactions. |
| OS without | Not specified |
| OS with | Not applicable; the majority of evidence is from preclinical studies, without detailed human data on overall survival impacts. |
| PFS without | Not specified |
| PFS with | Not applicable; current research has not progressed to detailed assessments of progression-free survival in cancer patients. |
| Usefulness Rating | 3 |
| Usefulness Explanation | Not specified |
| Toxicity Level | 1 |
| Toxicity Explanation | Garlic is used as a dietary supplement and is generally well-tolerated by most people. The most common side effects reported include gastrointestinal discomfort and a strong odor. There is currently not enough research to suggest that garlic as a treatment for glioblastoma has severe toxic side effects. So, it has a low toxicity level of 1. |
Notes: Garlic, recognized for centuries for its medicinal properties, has shown promise in preclinical studies for its potential anti-cancer effects. These include inducing apoptosis in glioblastoma cell lines and acting as a potent HDAC inhibitor. While these mechanisms suggest garlic could play a role in cancer prevention and possibly treatment, comprehensive clinical trials are needed to substantiate its efficacy and determine its therapeutic utility in oncology.
From Ben Williams Book: Not specified
Loading comments...
